Influence of debrisoquin (Declinax) on adrenergic function and norepinephrine metabolism.
D000578:Amidines / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002396:Catechols / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects; D003042:Cocaine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000378:metabolism; D010477:Perfusion; D051381:Rats; D013997:Time Factors; D014316:Tritium
D000578:Amidines; D000959:Antihypertensive Agents; D002395:Catecholamines; D002396:Catechols; D007546:Isoquinolines; D008996:Monoamine Oxidase Inhibitors; D009647:Normetanephrine; D014316:Tritium; D003042:Cocaine; D009638:Norepinephrine